Background hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide and it is one of the major causes of death, because of its high frequency and poor prognosis. Hepatocellular carcinoma is now a common malignancy in Egypt which usually develops on top of liver cirrhosis secondary to viral infection, as hepatitis C viruses increased the risk of HCC in the Egyptian patients. Aim of the Work was to verify the possibility of using the plasma squamous cell carcinoma antigen level as a tumor marker for hepatocellular carcinoma and to evaluate its prognostic value in management of HCC. Patients and Methods the study included 60 subjects divided into three groups: group I was 30 patients with hepatocellular carcinomas, group II was 15 patients with liver cirrhosis and group III was 15 normal subjects serving as a control group. Follow up of the patients who had HCC and undergone either RFA or TACE will be done after 1 month by measuring serum level of alfa feto protein & SCCA. Results the plasma SCCA level was significantly higher in group I patients (with HCC), than in the group II patients (cirrhosis) and control group. SCCA showed direct significant correlation with the most of laboratory data specially AST, INR, number and size of lesion and its values were decreased after intervention. Conclusion plasma SCCA is a sensitive and specific serum marker for the diagnosis and prognosis of HCC and combination of AFP and SCCA in screening and diagnosis of HCC yielded a better sensitivity in diagnosis of HCC.

No abstract

Background Hepatitis C Virus (HCV) infection is a major global health challenge; it is estimated that more than 80 million people are chronically infected worldwide, with 3–4 million new infections and 350 000 deaths occurring each year because of HCV-related complications. Aim of the work to determine the efficacy of Qurevo-Sovaldi-Ribavirin regimen as a retreatment strategy in NS5A inhibitors (Sofosbuvir & Daclatasvir) resistant patients infected with chronic hepatitis C virus. Patients and Methods An observational cross-sectional study was carried out on 20 chronic hepatitis C virus infected patients in The centre of HCV treatment at El Quabary specialized centers in Alexandria where large number of patients receiving their HCV treatment. Results all patients (20/20) achieved sustained virological response after 3 months of the last dose of treatment (SVR12). Conclusion the new retreatment strategy composed of the triple therapy Qurevo (Ombitasvir/Paritaprevir/Ritonavir)/Sofosbuvir/Ribavirin is effective in the treatment of chronic HCV infected patients previously treated with Sofosbuvir/Daclatasvir/Ribavirin for 12 weeks without achieving sustained virological response (Ns5a inhibitors resistant chronic HCV patients).

No abstract

Background: Vitamin D is a steroid hormone that is produced as a result of skin exposure to the sunlight. Vitamin D is essential to different organs and systems in the body as the bones, intestines, immune system, pancreas, brain, and control of cell cycle. Aim of the work: to assess the clinical relevance of vitamin D in colonic diseases (IBS and IBD) to know if there is a prevalence of vitamin D deficiency in these colonic diseases.Patients and Methods: This study was performed on 90 Egyptian patients who were classified into 3 groups; where Group 1 included 30 patients who have irritable bowel syndrome (IBS), Group 2 30 patients who have inflammatory bowel disease (IBD) whether Ulcerative Colitis (UC) or Crohn's Disease (CD) and Group 3 30 healthy personnel taken as Control group.Results: Regarding different vitamin D levels in the studied groups. In the control group, (20%) had deficient vitamin D level (< 20 ng/ml), (30%) had insufficient vitamin D level (20 -30 ng/ml), (50%) had optimal vitamin D level (>30 ng/ml). In IBS group, (60%) had deficient vitamin D level, (26.7%) had insufficient vitamin D level, (13.3%) had optimal vitamin D level. In the UC group, (66.7%) had deficient vitamin D level, (16.7%) had insufficient vitamin D level, (16.7%) had optimal vitamin D level. In CD group, (50%) had deficient vitamin D level, (33.3%) had insufficient vitamin D level, (16.7%) had optimal vitamin D level. Conclusion:The role of vitamin D deficiency in the pathogenesis of many chronic illnesses has raised the attention recently. Our study revealed that 25-OH-D3 deficiency is found more frequently among UC, CD and IBS patients than normal healthy controls. Thus, vitamin D prescription in these patients may help in improving these colonic diseases.